Cargando…

Effectiveness of gliclazide MR 60 mg in the management of type 2 diabetes: analyses from the EASYDia trial

BACKGROUND: Although the number of antihyperglycemic agents has expanded significantly, sulfonylureas (in particular gliclazide) remain an important option because of a variety of patient and health system factors. The large, real world, observational, and international EASYDia trial evaluated the e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leiter, Lawrence A., Shestakova, Marina V., Satman, Ilhan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894204/ https://www.ncbi.nlm.nih.gov/pubmed/29651307 http://dx.doi.org/10.1186/s13098-018-0331-8

Ejemplares similares

Hypoglycemia with gliclazide MR in women with type 2 diabetes. A continuous glucose monitoring study
por: Vianna, André G Daher, et al.
Publicado: (2015)

Role of Gliclazide MR in the Management of Type 2 Diabetes: Report of a Symposium on Real-World Evidence and New Perspectives
por: Khunti, Kamlesh, et al.
Publicado: (2020)

LEADER-4: blood pressure control in patients with type 2 diabetes and high cardiovascular risk: baseline data from the LEADER randomized trial
por: Petrie, John R., et al.
Publicado: (2016)

Pharmacokinetics and Anti-Diabetic Studies of Gliclazide Nanosuspension
por: Sampathi, Sunitha, et al.
Publicado: (2022)

The Factors Associated With Disease Mismanagement in Young Patients with Type 1 Diabetes: A Qualitative Study
por: Celik, Selda, et al.
Publicado: (2015)

Descriptive Regional Subanalysis of a Real-World Study in Patients with Type 2 Diabetes Treated with Gliclazide MR During Fasting: DIA-RAMADAN
por: Hassanein, Mohamed, et al.
Publicado: (2021)

The Role of Real-World Evidence in Treatment Decision-Making, Regulatory Assessment, and Understanding the Perspectives of People with Type 2 Diabetes: Examples with Gliclazide MR
por: Khunti, Kamlesh, et al.
Publicado: (2023)

Fabrication and Characterization of Gliclazide Nanocrystals
por: Ravouru, Nagaraju, et al.
Publicado: (2018)

Preparation and Crystallographic Analysis of Gliclazide Polymorphs
por: Rajamma, A. J., et al.
Publicado: (2015)

Safety and Efficacy of Gliclazide as Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Trials
por: Landman, Gijs W. D., et al.
Publicado: (2014)

Efficacy and safety of lixisenatide in patients with type 2 diabetes and renal impairment
por: Hanefeld, Markolf, et al.
Publicado: (2017)

Cost-Effectiveness of Increasing Influenza Vaccination Coverage in Adults with Type 2 Diabetes in Turkey
por: Akın, Levent, et al.
Publicado: (2016)

The Effects of Gliclazide, Metformin, and Acarbose on Body Composition in Patients with Newly Diagnosed Type 2 Diabetes Mellitus()
por: Wang, Hua, et al.
Publicado: (2013)

Effects of gliclazide add on metformin on serum omentin-1 levels in patients with type 2 diabetes mellitus
por: Al-Gareeb, Ali I., et al.
Publicado: (2016)

Acute Exfoliative Dermatitis/Erythroderma Secondary to Gliclazide
por: Al-Badawi, Saifaldeen, et al.
Publicado: (2023)

Attenuation of lipid peroxidation and atherogenic factors in diabetic patients treated with gliclazide and metformin
por: Banik, Sujan, et al.
Publicado: (2018)

CYP2C93 variant is associated with antidiabetes efficacy of gliclazide in Chinese type 2 diabetes patients
por: Zeng, Wotan, et al.
Publicado: (2016)

Gliclazide alone or in combination with atorvastatin ameliorated reproductive damage in streptozotocin-induced type 2 diabetic male rats
por: Öztaş, Ezgi, et al.
Publicado: (2019)

Comparison of gliclazide vs linagliptin on hypoglycemia and cardiovascular events in type 2 diabetes mellitus: A systematic review
por: Mohan, Viswanathan, et al.
Publicado: (2022)

Influence of curcumin on the pharmacodynamics and pharmacokinetics of gliclazide in animal models
por: Vatsavai, Leela Krishna, et al.
Publicado: (2016)

Influence of aprepitant on the pharmacodynamics and pharmacokinetics of gliclazide in rats and rabbits
por: Kura, Raghunandan Reddy, et al.
Publicado: (2018)

Bioavailability and Antidiabetic Activity of Gliclazide-Loaded Cubosomal Nanoparticles
por: Nasr, Mohamed, et al.
Publicado: (2021)

Effect of combined gliclazide/metformin treatment on oxidative stress, lipid profile, and hepatorenal functions in type 2 diabetic patients
por: Alsharidah, Mansour, et al.
Publicado: (2018)

Bioequivalence Study of Modified-Release Gliclazide Tablets in Healthy Volunteers
por: Rojanasthien, Noppamas, et al.
Publicado: (2012)

The influence of physical division of tablets on the variability of release kinetics of gliclazide
por: Wójcik-Pastuszka, Dorota, et al.
Publicado: (2018)

Interaction of p-synephrine on the pharmacodynamics and pharmacokinetics of gliclazide in animal models
por: Vatsavai, Leela Krishna, et al.
Publicado: (2018)

Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma
por: Cheng, Yang, et al.
Publicado: (2021)

Lipid-Based Gliclazide Nanoparticles for Treatment of Diabetes: Formulation, Pharmacokinetics, Pharmacodynamics and Subacute Toxicity Study
por: Nazief, Alaa Mohamed, et al.
Publicado: (2020)

Effects of liraglutide, metformin and gliclazide on body composition in patients with both type 2 diabetes and non‐alcoholic fatty liver disease: A randomized trial
por: Feng, Wen‐Huan, et al.
Publicado: (2018)

Protective Effects of Beta Glucan and Gliclazide on Brain Tissue and Sciatic Nerve of Diabetic Rats Induced by Streptozosin
por: Alp, Harun, et al.
Publicado: (2012)

Association between TCF7L2 Genotype and Glycemic Control in Diabetic Patients Treated with Gliclazide
por: Javorský, Martin, et al.
Publicado: (2013)

Inhibition of P-glycoprotein expression and function by anti-diabetic drugs gliclazide, metformin, and pioglitazone in vitro and in situ
por: Abbasi, Mehran Mesgari, et al.
Publicado: (2016)

Brain activities of streptozotocin-induced diabetic Wistar rats treated with gliclazide: Behavioural, biochemical and histomorphology studies
por: Ekong, Moses B., et al.
Publicado: (2022)

Comparison of nateglinide and gliclazide in combination with metformin, for treatment of patients with Type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone
por: Ristic, S, et al.
Publicado: (2006)

Gliclazide: Unmasking of glucose-6-phosphate dehydrogenase deficiency: case report
Publicado: (2021)

Cost Effectiveness of Insulin Glargine versus Neutral Protamin Hagedorn Insulin in the Treatment of Type 2 Diabetes Patients in Turkey
por: Satman, Ilhan, et al.
Publicado: (2013)

Cost-Effectiveness of Gliclazide-Based Intensive Glucose Control vs. Standard Glucose Control in Type 2 Diabetes Mellitus. An Economic Analysis of the ADVANCE Trial in Vietnam
por: Nguyen-Thi, Hai-Yen, et al.
Publicado: (2020)

Effect of Gliclazide or Gliclazide plus Metformin Combination on Glycemic Control in Patients with T2DM in India: A Real-World, Retrospective, Longitudinal, Observational Study from Electronic Medical Records
por: Polavarapu, Nareen Krishna, et al.
Publicado: (2020)

Clinical Effectiveness and Safety of Gliclazide MR and Linagliptin Combination in the Management of Patients With T2DM and Chronic Kidney Disease (CKD) Switched From Glimepiride - a Real-World, Retrospective, Observational Study
por: Bhattacharyya, Supratik, et al.
Publicado: (2021)

Ser1369Ala Variant in Sulfonylurea Receptor Gene ABCC8 Is Associated With Antidiabetic Efficacy of Gliclazide in Chinese Type 2 Diabetic Patients
por: Feng, Yan, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_c254s3hos0o3ph1efgtck7jkkc